News | July 11, 2007

GE, Abbott Labs Call Off $8.13 Billion Diagnostics Deal

A WALL STREET JOURNAL ONLINE NEWS ROUNDUP
July 11, 2007 - General Electric Co. and Abbott Laboratories announced they have terminated GE's $8.13 billion deal to buy Abbott's primary in-vitro and point-of-care diagnostics businesses.

In separate statements, the companies said they were unable to agree on "final terms and conditions" of the proposed deal. As a result, according to GE's statement, the companies "agreed it was in the best interests of both companies to mutually terminate their agreement and discussions."

The acquisition would have marked GE's entry into what is known as "in vitro" diagnostics, or laboratory testing, while Abbott would have shed a unit growing more slowly than other parts of its business. In vitro" diagnostics generally test blood or urine for diseases from cancer to HIV. Germany's Siemens AG, a GE rival in medical equipment, entered the market last year by paying $5.3 billion for Bayer AG's diagnostic unit.

The Abbott unit had sales of roughly $2.5 billion last year. GE would also have acquired Abbott's smaller point-of-care diagnostic group, which makes testing tools used at the bedside in hospitals, among other diagnostic tools.

Source: The Wall Street Journal Online

For more information: www.gehealthcare.com and www.abbott.com

Related Content

RaySafe Introduces Pro-Slit Camera for Accurate Focal Spot Measurement
Technology | Digital Radiography (DR) | June 27, 2017
Unfors RaySafe recently introduced the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand.
IBA Dosimetry Americas Announces New Exclusive Canadian Distributor for Radiotherapy Products
News | Radiation Therapy | April 28, 2017
April 28, 2017 — IBA (Ion Beam Applications S.A.) announced the Dosimetry Americas division has recently partnered wi
Medsquare, VirtualDose CT module, organ dose calculation, DACS Radiation Dose Monitor, RDM
Technology | Radiation Dose Management | March 24, 2017
Medsquare announced the integration of the organ dose module VirtualDose CT into its DACS (dose archive and...
Konica Minolta, AeroDR wireless flat panel detectors, AeroRemote Monitoring Service, digital radiography, RSNA 2017
Technology | Digital Radiography (DR) | March 10, 2017
Konica Minolta HealthcareAmericas Inc. recently announced the launch of itsAeroRemote cloud-based, active monitoring...
IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.
News | Radiation Therapy | February 07, 2017
IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready...
Virtual Phantoms, Qaelum, radiation dose monitoring, organ dose data
News | Quality Assurance (QA) | January 16, 2017
January 16, 2017 — Qaelum NV announced recently that they have entered into a partnership to bring the VirtualDose co
Technology | Quality Assurance (QA) | January 10, 2017
January 10, 2017 — Mobius Medical Systems LP announced in December that DoseLab, the complete TG-142 solution, now fu
SPECT-CT, 3-D printing, University of Wurzburg, Germany, Johannes Tran-Gia, dosimetry calibration

SPECT/CT reconstructions and VOIs used for determination of calibration factors for the adult kidney filled with Lu-177 (A) and the corresponding sphere filled with I-131 (B). Credit: University of Würzburg

News | 3-D Printing | January 06, 2017
In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images. Optimal...
Sponsored Content | Videos | Quality Assurance (QA) | December 20, 2016
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central...
Multidata Systems International Corp, water phantom, FDA warning
Feature | Radiation Therapy | October 21, 2016 | Dave Fornell
October 21, 2016 — The U.S.
Overlay Init